Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Xenon Pharmaceuticals Inc.

< Previous 1 2 3 Next >
News headline image
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Proposed Public Offering
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Present at Upcoming Investor Conferences
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Reports Third Quarter 2025 Financial Results & Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Report Q3 2025 Financial Results on November 3, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Reports Second Quarter 2025 Financial Results & Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Report Q2 2025 Financial Results on August 11, 2025
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Joins the Russell 3000® and Russell 2000® Indexes
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.